REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Feb 1, 2016
Insider Transaction Report
Form 4
Jeong Tae Heum
DirectorCFO
Transactions
- Award
Stock Option (right to buy)
2016-01-28+98,853→ 98,853 totalExercise: $0.35From: 2017-01-28Exp: 2026-01-28→ Common Stock (98,853 underlying) - Award
Stock Option (right to buy)
2016-01-28+100,000→ 100,000 totalExercise: $0.35Exp: 2026-01-28→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]One quarter of the option vests and becomes exercisable on January 28, 2017, and thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month following such date until fully vested.